App-Quantinova.ai

PREDICTORS OF EARLY, LATE AND VERY LATE (UP TO 12 YEARS) STENT THROMBOSIS FOLLOWING DRUG-ELUTING STENT IMPLANTATION IN DAILY PRACTICE: A SUBANALYSIS OF THE DESIRE REGISTRY

Ricardo A. Costa - American College of Cardiology (ACC) , 2015

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Venous thrombosis

N/A

FINAL FIVE-YEAR RESULTS OF THE PLATINUM RANDOMIZED TRIAL COMPARING PLATINUM CHROMIUM PROMUS ELEMENT AND COBALT CHROMIUM PROMUS/XIENCE V EVEROLIMUS-ELUTING STENTS IN WORKHORSE LESIONS

Gregg Stone - American College of Cardiology (ACC) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Promus Element

THROMBOSIS AFTER BIORESORBABLE VASCULAR SCAFFOLD IMPLANTATION: ANGIOGRAPHIC AND OCT FINDINGS

Serban Puricel - American College of Cardiology (ACC) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Everolimus

DOES CALCIUM BURDEN IMPACT ON CULPRIT LESION MORPHOLOGY AND CLINICAL

Peiren Shan - American College of Cardiology (ACC) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

CANGRELOR IN ELDERLY PATIENTS UNDERGOING PCI: FINDINGS FROM CHAMPION-PHOENIX

Matthew Cavender - American College of Cardiology (ACC) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Clopidogrel bisulfate

CARDIAC CATHETERIZATION AND PERCUTANEOUS CORONARY INTERVENTION IN PATIENTS WITH END STAGE LIVER DISEASE

Nabil Noureddin - American College of Cardiology (ACC) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

REAL-WORLD COMPARISON BETWEEN 1ST AND 2ND GENERATION DRUG-ELUTING STENTS: INSIGHTS FROM THE DESIRE REGISTRY

Jose de Ribamar Costa - American College of Cardiology (ACC) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

THE EFFECTS OF PREDILATION WITH SCORING BALLOON COMPARED TO CONVENTIONAL BALLOON ON COBALT-CHROMIUM STENT EXPANSION ANALYZED WITH OPTICAL COHERENT TOMOGRAPHY

Kentaro Jujo - American College of Cardiology (ACC) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Everolimus

LONG-TERM (FIVE-YEAR) CLINICAL EVALUATION OF THE RESOLUTE CORONARY ZOTAROLIMUS-ELUTING STENT: THE RESOLUTE US CLINICAL TRIAL

Martin Leon - American College of Cardiology (ACC) , 2015

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Venous thrombosis

ZoMaxx

ZILVER PTX DRUG-COATED PERIPHERAL ARTERY STENT USE IN A U.S. MULTICENTER REGISTRY

Karan Sarode - American College of Cardiology (ACC) , 2015

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Venous thrombosis

Zilver PTX

LONG-TERM DUAL ANTIPLATELET THERAPY WITH TICAGRELOR AFTER DRUG-ELUTING STENTS: RESULTS OF A DECISION ANALYTIC MODEL

Pallav Garg - American College of Cardiology (ACC) , 2015

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

Clopidogrel bisulfate

IMPACT OF FULL METAL JACKET WITH SECOND GENERATION DRUG ELUTING STENTS FOR CHRONIC TOTAL OCCLUSION

Mahek Kishor Shah - American College of Cardiology (ACC) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

ZoMaxx

COMPARATIVE ANALYSIS OF ANGIOGRAPHIC RESPONSE TO INITIAL WIRING OF TOTALLY OCCLUDED CORONARY ARTERIES IN STEMI

Daniel Garcia - American College of Cardiology (ACC) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

INCIDENCE AND CLINICAL IMPLICATIONS OF PERI-STENT CONTRAST STAINING IN VARIOUS TYPES OF DRUG-ELUTING STENT

Michitaka Nakamura - American College of Cardiology (ACC) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

BAYESIAN META-ANALYSIS IDENTIFIES THE INTERVENTIONAL ADVANCES RESPONSIBLE FOR THE DIMINISHED BLEEDING ADVANTAGE OF BIVALIRUDIN OVER HEPARIN

John A. Bittl - American College of Cardiology (ACC) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Bivalirudin

VERY LONG-TERM OUTCOMES AFTER SIMPLE VERSUS COMPLEX STENTING OF CORONARY ARTERY BIFURCATION LESIONS

Masahiro Yamawaki - American College of Cardiology (ACC) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

EXPERIENCE TREATING IN-STENT RESTENOSIS LESIONS FROM A MULTICENTER REGISTRY

Subhash Banerjee - American College of Cardiology (ACC) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

LONG-TERM CLINICAL OUTCOMES WITH EVEROLIMUS-ELUTING STENTS AND SIROLIMUS-ELUTING STENTS: AN UPDATED META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS

Toshiaki Toyota - American College of Cardiology (ACC) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Everolimus

TWO-YEAR CLINICAL OUTCOME OF THE NOBORI BIOLIMUS-ELUTING STENT VERSUS XIENCE/PROMUS EVEROLIMUS-ELUTING STENT IN REAL-WORLD CLINICAL PRACTICE

Shoichi Kuramitsu - American College of Cardiology (ACC) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Everolimus

THE SAFETY AND EFFICACY OF ULTRA-LONG 2ND GENERATION DRUG ELUTING STENT IMPLANTATION

Yohsuke Honda - American College of Cardiology (ACC) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

ZoMaxx

Filters

7277 Abstracts